Results 91 to 100 of about 92,867 (160)

GLUT5-Driven Gut-Liver Axis Injury Mediating Olanzapine-Induced NAFLD and Dapagliflozin Intervention. [PDF]

Drug Des Devel Ther
Chen X, Zhang Y, Wang J, Chen L, He SM, Wang DD.   +5 more
europepmc   +1 more source

A human liver organoids-on-chip for the assessment of drug-induced liver injury. [PDF]

BMC Pharmacol Toxicol
Chen X, Bao F, Liu J, Wang Y, Tao T, Zhang G, Qin J.   +6 more
europepmc   +1 more source

Editorial: Prevention and treatment of metabolic diseases using bioactive metabolites of herbal medicines also used as foods. [PDF]

Front Pharmacol
Wei RR, Liu WM, Yuan CS, Zhang CL, Sang ZP, Ma QG.   +5 more
europepmc   +1 more source

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy. [PDF]

Liver Int
Kirchner T, Dalekos GN, Zachou K, Robles-Díaz M, Andrade RJ, Sebode M, Lohse A, Janik MK, Milkiewicz P, Kolev M, Semmo N, Bruns T, Gevers TJ, Beretta-Piccoli BT, Wedemeyer H, Jaeckel E, Taubert R, Engel B, pIgG study group.   +18 more
europepmc   +1 more source

Risks, Benefits, and Molecular Targets of Fenugreek Administration in the Treatment of Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Vittal M, Menegassi B, Vinciguerra M.
europepmc   +1 more source

Mechanistic insights into atorvastatin-induced hepatotoxicity: molecular pathways, clinical relevance, and strategies for safer personalized therapy. [PDF]

Clin Exp Med
Abdel-Rasol MA, El-Sayed WM.
europepmc   +1 more source

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. [PDF]

In Vivo
Takada S, Umehara K, Watanabe K.
europepmc   +1 more source

Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review). [PDF]

Mol Med Rep
Yu J, Qu H, Xu W, Fang Y, Wang N, Shi W.
europepmc   +1 more source

Exploring the Protective Effect of Gastrodia elata Extract on D-Galactose-Induced Liver Injury in Mice Based on the PI3K/Akt Signaling Pathway. [PDF]

Curr Issues Mol Biol
Han L, Zhai H, Ma X, Li H, Ren Q, Liu J, Zhang Z, Li X, Zhang Q, Sun X.   +9 more
europepmc   +1 more source

Functional roles and regulatory mechanisms of paeonol in the treatment of liver disease. [PDF]

Nat Prod Bioprospect
Shu M, Fang M, Xu T, Yan Q.
europepmc   +1 more source